The micronucleus (MN) test has been carefully characterised in four human tumour cell lines of widely differing radiosensitivity. Two radioresistant bladder carcinoma cell lines (MGH-U1 and RT1 12), one sensitive medulloblastoma cell line (D283MED) and a sensitive neuroblasoma cell line (HX142) were used. The number of MN per Gy of ionising radiation was 0.13 for HX142, 0.17 for D283MED, 0.21 for RT1 12 and 0.26 for MGH-U1. This does not rank the cell lines in the same order of radiosensitivity as clonogenic cell survival where the surviving fraction at 2 Gy (SF2) was 0.11 for HX142, 0.2 for D283MED, 0.62 for RTI 12 and 0.53 for MGH-U1. This discrepancy between MN formation and cell death leaves doubt as to the potential usefulness of the MN test as a rapid assay of radiosensitivity but it has potential implications for the mechanistic basis of radiosensitivity in these cells.
Micronuclei (MN) are formed when chromosomal fragments behave independently of the remaining chromosomes during the division of damaged cells. The presence of MN is thus considered to reflect genotoxic damage. The MN test has been applied to studies of environmental and industrial hazards (Heddle et al., 1983; Heddle et al., 1990; Meng & Zhang, 1990) . The relationship between genotoxicity, as measured by the MN test and cytotoxic damage following ionising radiation treatment has been investigated by a number of authors and a general correlation has usually been found between MN formation and slow growth or the absence of colony formation (Joshi et al., 1982; Stap & Aten, 1990) . Also MN frequency changes in proportion to cell kill when a given cell type is irradiated under various conditions (Midander & Revesz, 1980 (Peters et al., 1986; Streffer et al., 1986) . Morley (1985, 1986) (Revell, 1983 Since a large proportion of human tumour cells are aneuploid this complication could be a significant factor. In the present study we have therefore studied four human tumour cell lines of widely differing radiosensitivity in order to investigate the relationship between cell kill, as assessed by a clonogenic assay, and micronucleus formation.
Materials and methods

Cell lines
Four human tumour cell lines were used: HX142 is a neuroblastoma cell line which was originally established from xenografted tumour tissue (Deacon et al., 1985) ; RT1 12 and MGHU1 are both bladder carcinoma cell lines (Kato et al., 1977; Masters et al., 1986) ; D283MED is a medulloblastoma cell line (Friedman et al., 1985) Figure 2 shows the effect of Cytochalasin-B on MN frequency at 3 days. In the absence of Cytochalasin-B counts were made in all cells rather than just BNC and in this situation levels of MN per cell were extremely low in all cases: 0.03 per cell for MGH-Ul, 0.02 for RT112, 0.003 for D283MED and 0.02 for HX142. As expected, these levels were generally lower than those obtained in the presence of Cytochalasin-B due to the dilution effect of the separation of daughter nuclei into separate cells. A plateau of MN frequency is reached at 0.5fLgml'1 for MGH-U1, D283MED
and HX142, and at 1.0tLgml-' for RT112. We selected 1.Oigml-' Cytochalasin-B for all the cell lines, which led to 60-80% of cells being binucleate on day 3 for MGH-Ul, HX142 and RT112 but a lower number of BNC (30%) for D283MED.
Time of MN expression Sufficient time is needed after irradiation to allow cells to progress through one nuclear division in order to display MN formation. Figure 1 ) to MN frequency (from data points in Figure  4 ). Data First of all the lack of synchronisation in all the cell lines would lead to MN having a reduced effect on colony formation as the damaged G2/M cells (and perhaps at least some of those in S-phase) would still form colonies if only one daughter cell was affected. This would lead to a MN:lethal lesion ratio greater than 1. In each case here this ratio is less than 1. The sensitive cell lines (HX142 and D283MED) do have more cells in G1 for which each MN is more likely to contain chromosomal fragments which would then reduce colony formation. However, the scale of the differences in MN per lethal lesion between the cell lines is unlikely to be fully explained by these differences in cell cycle distribution.
The influence of ploidy should also be considered as Revell (1983) found that cells with more chromosomes suffered increased damage but they also exhibited greater tolerance of that damage. The four cell lines in this study all have very similar modal chromosome numbers, therefore ploidy would seem to be unimportant. Nevertheless, the cell lines do not have normal karyotypes, so that perhaps karyotypic instability or functional hemizygosity are influencing these results.
The conclusion from the data with the sensitive lines is that MN loss in the first division after irradiation is not a large contributor to the death in these cells. At the extreme this may suggest that they are dying from a non-mitotic death. Apoptosis has recently been reported to be a cause of death in gamma-irradiated cells (Stephens et al., 1991) but we have found that although apoptosis can be detected in D283MED this is not a significant effect in these cells (Ung & McMillan, in preparation) . Alternatively, these cell lines may be inefficient at converting chromosome fragments into MN or MN might only be expressed in later divisions after irradiation, i.e. the fragment exclusion probability at the first and subsequent divisions may differ between the cell lines. If this factor did differ between our cell lines we would have perhaps expected the distributions of MN per cell to differ for a given average number of MN per cell. Our ability to examine this is restricted due to the finding that the highest MN frequency detected in HX142 and D283MED is low for the dose range studied. However, in our analysis of the distributions of the number of MN per cell (data not shown) we have been unable to detect differences between the cell lines. A detailed analaysis of the cytogenetic changes induced by radiation in these cells is needed to investigate these possibilities.
Overall the data presented suggest that the MN test may not be a satisfactory rapid test of the radiosensitivity of human tumour cells, although it remains to be fully tested within a single tumour type. However, it may provide useful information regarding the way different cells handle radiation-induced damage.
We are grateful to Professor G.G. Steel and Mr J.H. Peacock for their advice throughout this project and to Dr D. Bigner for providing the D283MED cell line. Also we are indebted to Mrs S. Stockbridge and Miss R. Couch for the careful preparation of this manuscript. This study was supported by the Cancer Research Campaign and the Medical Research Council.
